Evaluation of the new supraglottic airway S.A.L.T to aid blind orotracheal intubation: A pilot study

Abstract
Background and Objective:
Supraglottic Airway Laryngopharyngeal Tube (S.A.L.T) is a new airway gadget conceived as an effective device to facilitate blind oro-tracheal intubation. Literature review showed no available clinical study on human
subjects. The aim of our study was to evaluate S.A.L.T as an adjunct to blind oro-tracheal intubation.
Methods:
Study design: Single centre, Single group, Open label, Prospective,
Interventional pilot study. Study Group: 30 adult patients of either sex belonging to ASA I and II, scheduled for elective surgery under General anaesthesia. Patients were pre-medicated with inj. Glycopyrrolate 0.2 mg and inj. Midazolam 2 mg and induced with Inj. Propofol 2 mg/kg IV. After inj.
Suxamethonium 1.5 mg/kg IV, S.A.L.T was inserted and a size 7.0 ID cuffed ETT was inserted through it immediately. The time period, from insertion of the S.A.L.T to the insertion of the ETT was noted. A successful intubation was defined as to insert SALT and intubate through it within 2 minutes irrespective
of the number of attempts. Airway trauma, if any was recorded.